Clinical isolates of agar-pitting, formate-fumarate-requiring, anaerobic gram-negative bacilli were recharacterized in consideration of the species descriptions of Bacteroides ureolyticus and the newly described B. gracilis, Campylobacter concisus, and Wolinella sp. During an 11-year period, 7.5% (101 of 1,341) of all specimens yielding anaerobes were found to contain an organism in this group. Of the 71 isolates that were available for study, 43 were B. ureolyticus, 23 were B. gracilis, and 5 were in the Wolinella-C. concisus group. The role in infection and patterns of antimicrobial susceptibility for B. ureolyticus and B. gracilis were studied. Review of the clinical data indicated that 83% of B. gracilis strains were recovered from patients with serious visceral or head and neck infection, whereas 73% of B. ureolyticus isolates were recovered from superficial soft-tissue or bone infections. The strains of B. ureolyticus were uniformly susceptible to the tested antimicrobial agents. B. gracilis, however, showed some striking resistance, with penicillin active against only 67% and the cephalosporins active against 67 to 84% of the isolates tested. The association of B. gracilis with serious deep-tissue infection, coupled with the relatively high frequency of antibiotic resistance, indicates that it is an important, previously unrecognized, pathogen.
The role of anaerobic gram-negative bacteria in infection has been well documented (4) . Pathogenic roles are best established for members of the Bacteroides fragilis and the pigmented Bacteroides groups; however, increasing information is available on the role of some of the less well known members of the family Bacteroidaceae in clinical infections (12) . Recognition of the importance of these other organisms is related to improvement in laboratory recovery of these potential pathogens from clinical specimens and to new taxonomic information.
Among the less well known members of the family Bacteroidaceae is the group of bile-sensitive, formatefumarate-requiring organisms that are usually recognized by their agar-pitting capabilities. Historically, the classification and nomenclature for this group of organisms has been confusing. Initially, Bacteroides corrodens was the name applied to both anaerobic and facultative gram-negative bacilli that formed "corroding" colonies on agar surfaces (3, 8) . In 1972, however, Jackson and Goodman renamed the facultative strains Eikenella corrodens and reserved the name Bacteroides corrodens for the strictly anaerobic strains (10) . Subsequently, Jackson and Goodman characterized and renamed this B. corrodens group as Bacteroides ureolyticus (11) . In addition, other strains of agar-corroding anaerobic bacilli, which did not conform to the description of B. ureolyticus, have been reported. In 1981, four new species of these agar-pitting bacilli were described based on their guanine-plus-cytosine DNA contents, DNA homologies, and cluster analyses of their phenotypic features (15 Antimicrobial susceptibility and beta-lactamase testing. MICs were determined by a brucella-laked blood agar dilution method, as described previously (14) . A qualitative assay for beta-lactamase was performed with the chromogenic cephalosporin nitrocefin (Cefinase; BBL Microbiology Systems). TTA" or pleural fluid 3 8 Tracheostomy suction (sputum) 0 lb Intra-abdominal or pelvic sample 4 6 Perirectal sample bThis patient had an aspiration pneumonia, and the only specimen obtainable was sputum suctioned through a tracheostomy. The clinical significance of this culture is uncertain. Table 2 summarizes the cases that yielded B. gracilis on culture. These patients ranged in age from 12 to 85. Of the 23 patients, 21 were male, but this was biased by the predominantly veteran population. Of the nine patients with pleuropulmonary infection, three were alcoholics, two had other underlying alterations of consciousness, and two had severe gingivitis. The two patients with brain abscess both had sinusitis as a contiguous source of infection. All cases of intra-abdominal abscess or peritonitis resulted from underlying biliary tree obstruction or appendiceal perforation. Overall, 19 of the 23 patients were cured with a variety of antimicrobial agents as well as appropriate surgical drainage procedures. There were four deaths among the patients, all of which were related to the infections involving B. gracilis.
RESULTS
Susceptibility testing revealed some notable differences (9), subdural empyema (17), bite wounds (7), pleuropulmonary infection (1), perirectal abscess (13) , and necrotizing fasciitis (6), among others. However, clinical reports from before 1978, when criteria for the identification of B. ureolyticus were strictly defined, must be interpreted cautiously. More recently, Duerden et al. re- ported the isolation of 103 strains of B. ureolyticus that do conform to the present taxonomic criteria for this species (2) . All of their isolates were recovered from fairly superficial necrotic or gangrenous lesions. Of the isolates, 42 were from perineal, genital or perianal sites, 16 were from gangrenous lesions of the lower extremities, 15 were from softtissue abscesses, and the remainder were from a variety of soft-tissue and dental sites. Similarly, the majority of B. ureolyticus isolates in our study were recovered from sites of soft-tissue infection. These were usually on the extremities and were mild.
B. gracilis was first described as a species in 1981. Previously, these bacteria would have been categorized under various other designations, including B. corrodens, "B. corrodens-like," "B. ureolyticus-like," or Bacteroides sp. The original isolation of B. gracilis was from a human gingival crevice; there have been no subsequent reports of isolation from other sources. Thus, although the closely related B. ureolyticus has been implicated as a pathogen in infections, B. gracilis has, to date, had no recognized pathogentic role. In this investigation, we identified 23 strains of B. gracilis and found 83% of them to be associated with serious visceral or head and neck infections. Anaerobic pleuropulmonary infections were the single largest disease category. Because all of the isolates of B. gracilis were recovered from polymicrobial infections, the role of B.
gracilis itself in the pathogenesis of these serious infections remains somewhat uncertain. However, the frequency of association of this species with serious anaerobic infections implies virulence.
Antimicrobial susceptibility testing revealed a strikingly high percentage (33%) of B. gracilis isolates to be resistant to penicillin. The usual mechanism of penicillin resistance among anaerobes (e.g., B. fragilis) is through the production of beta-lactamases. Beta-lactamase was not detected for any of our penicillin-resistant isolates of B. gracilis, although the use of a single assay method may not exclude this possibility (5) . The list of penicillin-resistant anaerobes that have been recovered from infections continues to grow. Empiric antimicrobial regimens for the treatment of a seriously ill patient with an anaerobic infection, including pleuropulmonary disease, should take this into account. The presence of B. gracilis may explain the failure of some cases of anaerobic infections, such as pleuropulmonary infections, to respond to penicillin, despite the absence of a recognized penicillinresistant pathogen. The significant resistance of B. gracilis to antimicrobial agents suggests that it may be more frequently encountered in the future, as it is selected out under the pressure of exposure to antimicrobial agents.
The taxonomy of agar-pitting, anaerobic, gram-negative bacilli has undergone recent revision, and several new species have been described. In our 11-year review of the clinical occurrence of these organisms, B. ureolyticus and B. gracilis accounted for 60 and 32% of such isolates, respectively. The association of B. gracilis with serious deep-tissue infection, coupled with the relatively high frequency of antibiotic resistance, indicates an important clinical role for this organism.
